胸腔镜肺叶切除术治疗原发性非小细胞肺癌的临床价值和安全性分析  

Effect and safety of thoracoscopic pulmonary lobectomy in the treatment of primary non-small-cell lung cancer

作　　者：耿玉六[1] 李安[1] 张保友[1] 王腾飞[1] 

机构地区：[1]皖北煤电集团总医院心胸外科,宿州234000

出　　处：《国际医药卫生导报》2013年第19期3013-3016,共4页International Medicine and Health Guidance News

摘　　要：目的 分析胸腔镜肺叶切除术治疗原发性非小细胞肺癌的临床价值和安全性.方法 将我院2010年5月至2013年2月收治的60例原发性非小细胞肺癌患者随机分为观察组（n=30）和对照组（n=30）,观察组患者采用胸腔镜肺叶切除术治疗,对照组患者采用常规开胸肺叶切除术治疗,然后分析两组患者的疗效和安全性.结果 观察组患者的手术时间、术中出血量、术后引流量、住院时间和并发症率都显著小于对照组患者（P＜0.05）,但是两组患者的淋巴结清扫数目差异无统计学意义（P＞0.05）.结论 胸腔镜肺叶切除术治疗非小细胞肺癌具有安全、创伤小、恢复快、并发症少等优势,可以作为治疗非小细胞肺癌的首选方法.Objective To analyze effect and safety of thoracoscopic pulmonary lobectomy in the treatment of primary non-small-cell lung cancer.Methods 60 patients with primary non-small-cell lung cancer in our hospital from May 2010 to February 2013 were randomly divided into observation group (n=30) and control group (n=30).Observation group was given thoracoscopic pulmonary lobectomy,while control group was given open thoracotomy.Then analyzed the effect and safety of two groups.Results The operation time,intraoperative blood loss,postoperative suction drainage,hospitalization time,and rate of complications in observation group were significantly lower than those in control group (P ＜ 0.05).However,there was no significant difference in the number of dissected lymph node between two groups (P ＞ 0.05).Conclusions Thoracoscopic pulmonary lobectomy in the treatment of non-small-cell lung cancer has many advantages,such as safety,minimal invasion,quick recovery,and few complications,which can be preferred method for non-small-cell lung cancer.

关 键 词：胸腔镜 肺叶切除术 非小细胞肺癌 

分 类 号：R734.2[医药卫生—肿瘤]